| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/19/2007 | US7232833 For therapy and prophylaxis of bacterial infections |
| 06/19/2007 | US7232820 Thiadiazole-amine compounds for the treatment of neurodegenerative disorders |
| 06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 06/19/2007 | US7232818 Compounds for enzyme inhibition |
| 06/19/2007 | US7232792 3-heterocyclyl-substituted benzoyl derivatives |
| 06/14/2007 | WO2007067511A2 Morpholine carboxamide prokineticin receptor antagonists |
| 06/14/2007 | WO2007067444A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | WO2007066617A1 Condensation reaction by metal catalyst |
| 06/14/2007 | WO2007066103A1 Pyrimidine derivatives as class i pi3k inhibitor |
| 06/14/2007 | WO2007065940A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| 06/14/2007 | WO2007065518A1 Pyridiazinone derivatives for tumour treatment |
| 06/14/2007 | WO2006034419A3 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135485 Novel mch receptor antagonists |
| 06/14/2007 | US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135447 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 06/14/2007 | US20070135442 Chroman compounds |
| 06/14/2007 | US20070135434 Sulfonyloxy derivatives |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135432 Mitotic kinesin KSP inhibitors; antiproliferative agents; 2-methylpyrimidin-4-ones |
| 06/14/2007 | US20070135431 Inhibitors of histone deacetylase for the treatment of disease |
| 06/14/2007 | US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/14/2007 | US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors |
| 06/14/2007 | US20070135424 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 06/14/2007 | US20070135423 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 06/14/2007 | US20070135418 Compositions and methods relating to novel compounds and targets thereof |
| 06/14/2007 | US20070135403 Substituted 2,5-diaminomethyl-1H-pyrrole compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | CA2632643A1 Chemical compounds |
| 06/14/2007 | CA2632512A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | CA2632217A1 Pyridiazinone derivatives for the treatment of tumours |
| 06/14/2007 | CA2631291A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyridyl hydrazones |
| 06/13/2007 | EP1794167A1 Substituted isoxazoles as fungicides |
| 06/13/2007 | EP1794156A2 Trombopoietin receptor agonists |
| 06/13/2007 | EP1794155A1 Oxazole derivatives as her tyrosine kinase inhibitors |
| 06/13/2007 | EP1794154A1 Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 06/13/2007 | EP1794153A1 1,2,3-triazole derivatives as receptor tyrosine kinase inhibitors |
| 06/13/2007 | EP1794149A2 Bicyclic amides as kinase inhibitors |
| 06/13/2007 | EP1794136A1 Aryl-ureido benzoxazinone compounds |
| 06/13/2007 | EP1794120A2 Peptidase inhibitors |
| 06/13/2007 | EP1793826A2 Chemical compounds |
| 06/13/2007 | EP1611122B1 Substituted pyrazole compounds |
| 06/13/2007 | EP1416931B1 Inhibitors of polyq-aggregation |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | CN1980921A Dioxazinyl-substituted thienylsulphonylaminocarbonyl compounds |
| 06/13/2007 | CN1980920A Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 06/13/2007 | CN1980919A Compounds and compositions as ppar modulators |
| 06/13/2007 | CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof |
| 06/13/2007 | CN1980916A Chemokine receptor binding heterocyclic compounds |
| 06/13/2007 | CN1980904A CETP inhibitors |
| 06/13/2007 | CN1980895A 1-aryl-4-substituted isoquinolines |
| 06/13/2007 | CN1978445A Compound, and its preparing method and use |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230099 Heterocyclic inhibitors of MEK and methods of use thereof |
| 06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230017 For therapy of neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems |
| 06/12/2007 | US7229992 Process for the preparation of a piperazine derivative |
| 06/12/2007 | US7229991 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | US7229973 pH-sensitive polymeric micelles for drug delivery |
| 06/12/2007 | US7229842 Metal chelate containing compositions for use in chemiluminescent assays |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007063934A1 Alicyclic heterocyclic compound |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063868A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | WO2007063123A1 Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof |
| 06/07/2007 | WO2007063012A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 06/07/2007 | WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles |
| 06/07/2007 | WO2007062773A1 Oxadiazole derivatives with crth2 receptor activity |
| 06/07/2007 | WO2007043677A9 Hydrazide compound and pesticidal use of the same |
| 06/07/2007 | WO2007043653A9 Benzimidazole-5-carboxamide derivative |
| 06/07/2007 | WO2007030940A3 Methods of modulating neurotrophin-mediated activity |
| 06/07/2007 | WO2007024949A3 Alpha2c adrenoreceptor agonists |
| 06/07/2007 | WO2007016610A3 Antibacterial agents |
| 06/07/2007 | WO2007014290A3 Fungicidal carboxamides |
| 06/07/2007 | WO2006138350A3 Chemokine receptor binding compounds |
| 06/07/2007 | WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 06/07/2007 | US20070129550 Amino acids with affinity for the alpha-2-delta-protein |
| 06/07/2007 | US20070129544 Novel heteroaryl substituted piperidine derivatives which are L-CPT1 inhibitors |
| 06/07/2007 | US20070129408 New compounds for the treatment of neurological, psychiatric or pain disorders |
| 06/07/2007 | US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds |
| 06/07/2007 | US20070129367 Pyridine derivatives as cb2 receptor modulators |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129358 Sbstituted chroman derivatives, processes for their preparation and their use as antiinflammatory agents |
| 06/07/2007 | US20070129355 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | CA2636314A1 Arylmethylene urea derivative and use thereof |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632181A1 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 06/07/2007 | CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/07/2007 | CA2631652A1 Oxadiazole derivatives with crth2 receptor activity |
| 06/07/2007 | CA2630460A1 Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |